Tower Research Capital (TRC)’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.3K | Buy |
5,500
+4,490
| +445% | +$26.4K | ﹤0.01% | 3343 |
|
|
2025
Q1 | $8.47K | Sell |
1,010
-796
| -44% | -$6.68K | ﹤0.01% | 3888 |
|
|
2024
Q4 | $13.4K | Sell |
1,806
-4,261
| -70% | -$31.7K | ﹤0.01% | 3528 |
|
|
2024
Q3 | $35.2K | Buy |
6,067
+211
| +4% | +$1.22K | ﹤0.01% | 2922 |
|
|
2024
Q2 | $38.9K | Buy |
5,856
+5,613
| +2,310% | +$37.3K | ﹤0.01% | 3289 |
|
|
2024
Q1 | $3.17K | Sell |
243
-9,303
| -97% | -$121K | ﹤0.01% | 4911 |
|
|
2023
Q4 | $122K | Buy |
9,546
+5,465
| +134% | +$69.7K | ﹤0.01% | 2494 |
|
|
2023
Q3 | $53.5K | Buy |
4,081
+2,296
| +129% | +$30.1K | ﹤0.01% | 2493 |
|
|
2023
Q2 | $45.7K | Buy |
1,785
+752
| +73% | +$19.2K | ﹤0.01% | 2638 |
|
|
2023
Q1 | $26K | Sell |
1,033
-3,020
| -75% | -$76K | ﹤0.01% | 3172 |
|
|
2022
Q4 | $94K | Sell |
4,053
-1,310
| -24% | -$30.4K | ﹤0.01% | 1895 |
|
|
2022
Q3 | $118K | Buy |
5,363
+1,397
| +35% | +$30.7K | ﹤0.01% | 2432 |
|
|
2022
Q2 | $57K | Buy |
3,966
+2,558
| +182% | +$36.8K | ﹤0.01% | 2763 |
|
|
2022
Q1 | $27K | Buy |
1,408
+662
| +89% | +$12.7K | ﹤0.01% | 3261 |
|
|
2021
Q4 | $14K | Buy |
746
+413
| +124% | +$7.75K | ﹤0.01% | 4108 |
|
|
2021
Q3 | $9K | Buy |
333
+245
| +278% | +$6.62K | ﹤0.01% | 4468 |
|
|
2021
Q2 | $3K | Buy |
+88
| New | +$3K | ﹤0.01% | 4961 |
|